Jesús Cebrecos

Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study

Jesús Cebrecos, James D. Carlson, Gregorio Encina et al. · Clinical Therapeutics · 2021 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial

Eugene R. Viscusi, Oscar A. de León-Casasola, Jesús Cebrecos et al. · Pain Practice · 2022 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of co‐crystal of tramadol‐celecoxib (<scp>CTC</scp>) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial (<scp>STARDOM2</scp>)

R. M. Langford, Adelaida Morte, Mariano Sust et al. · European Journal of Pain · 2022 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain

R. M. Langford, César Margarit, Adelaida Morte et al. · Current Medical Research and Opinion · 2024 · 18 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +11

E‐52862—A selective sigma‐1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double‐blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy

Rafael Gálvez, V. Mayoral, Jesús Cebrecos et al. · European Journal of Pain · 2024 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17